Insulet | PODD - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.06B 69M 2026-03
Align Technology USD 4.23B 83.03M 2026-06
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Cardinal Health USD -2.88B 51M 2026-06
Cooper Companies USD 8.33B 89.1M 2026-06
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
ICU Medical USD 2.15B 39.92M 2026-06
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 50.23B 160M 2026-06
Merit Medical Systems USD 1.68B 53.08M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Solventum Corp USD 4.8B 169M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
West Pharmaceutical Services USD 2.99B 200K 2026-06
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06